| PUBCHEM ID |
10214
|
| UNII |
5TH3ERG159
|
| Preferred Term |
3'-PHOSPHOADENOSINE 5'-PHOSPHOSULFATE
|
| CAS |
482-67-7
|
| INCHIKEY |
GACDQMDRPRGCTN-KQYNXXCUSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
Nc1c2ncn([C@H]([C@H]3O)O[C@@H](CO[P@@](O)(OS(O)(=O)=O)=O)[C@@H]3OP(O)(O)=O)c2ncn1
|
| Total Surface Area |
299,99
|
| Relative PSA |
0,74392
|
| TPSA |
303,97
|
| cLogS |
1,477
|
| MW |
507,265
|
| cLogP |
-9,2263
|
| H-Acceptors |
18
|
| H-Donors |
6
|
| Ro5 violations |
3
|
| Druglikeness |
-34,793
|
| DrugScore |
0,369270736678334
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
-0,4436
|
| P-glycoprotein Substrate |
Non-substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Plasma membrane
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
Low FHMT
|
| Fish Toxicity II |
1,5537
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,366
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,5116
|
| Carcinogenicity (Three-class) |
Non-required
|